1) Takahashi E: Status of treatment for lifestyle-related diseases based on Japan society of ningen dock database. Ningen Dock 2013; 28: 732-743 [in Japanese]
2) Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists’ (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278
3) Cannon CP, Blazing MA, Giugliano RP, et al; IMPROVE-IT Investigators: Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015; 372: 2387-2397
4) Jellinger PS, Handelsman Y, Rosenblit PD, et al: American association of clinical endocrinologists and American college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract 2017; 23 (Suppl 2): 1-87